ABSTRACT In-vitro experiments using 203Pb were performed to identify the lead binding components in human peripheral blood. The distribution of lead in plasma, in the red cell membrane, and within the red cell was also investigated. Studies of the distribution of 203Pb in whole blood showed that at a lead concentration of 2 45 ,umol/l (50 ug/100 ml) about 94 % of lead had been incorporated by the erythrocytes and 6 % remained in the plasma. responsible for the lead uptake; one is protein and the other a non-protein, probably a phenolic compound. This hypothesis has been discounted by Clarkson and Kench,4 who suggested that lead exists in the blood as a peptised lead phosphate-sol, the groups of which are probably aggregated on the surface of the cell to form a larger particulate. On the other hand, recent studies by Barltrop and Smith7 8 using tracer 203Pb do not confirm that lead has an affinity to the red blood cell membrane. These authors separated the 203Pb-containing fraction of RBC by sephadex gel filtration and ultracentrifugation. Lead was found attached to the intracellular constituents rather than the stromal membrane, and to a molecule similar in size to the haemoglobin polypeptide. White,9 however, and Selhi and White'0 believe that the attachment takes place in the erythrocyte membrane, which results in alteration of membrane protein conformation.
lipid contained about 21 % of the 203Pb, the remainder being in the aqueous plasma. SDS polyacrylamide gel electrophoresis of blood plasma showed that almost 90 % of the 203Pb was present in the albumin fraction; the remainder was likely to be associated with high molecular weight globulins. Several The mechanism by which lead transfers from the external to the internal environment is not fully understood, but it is generally agreed that this metal is transported by the peripheral blood.' 2 Numerous studies on the uptake and binding of lead with peripheral blood have not succeeded in showing clearly either the mechanism of interaction or the binding site. Mortensen and Kellog3 suggested that lead is bound to the red blood cell or to the plasma, and only a small amount is in a free ionised form. Clarkson and Kench4 showed that lead has a high affinity for the erythrocytes.
The precise lead binding site in the red cell, however, is still unknown. On the one hand, several investigators consider that the most likely sites of fixation are in the cell membrane.5 Reddi6 proposed that there may be two components in the red cell exists in the blood as a peptised lead phosphate-sol, the groups of which are probably aggregated on the surface of the cell to form a larger particulate. On the other hand, recent studies by Barltrop and Smith7 8 using tracer 203Pb do not confirm that lead has an affinity to the red blood cell membrane. These authors separated the 203Pb-containing fraction of RBC by sephadex gel filtration and ultracentrifugation. Lead was found attached to the intracellular constituents rather than the stromal membrane, and to a molecule similar in size to the haemoglobin polypeptide. White,9 however, and Selhi and White'0 believe that the attachment takes place in the erythrocyte membrane, which results in alteration of membrane protein conformation.
The identification of specific lead binding sites in the blood is hindered by experimental difficulties such as the necessity to detect and to measure trace amounts of lead in microsamples of subcellular Solubilisation of red cell membrane before electrophoresis was achieved by adding 0-5 ml of a solution containing 3% SDS, 0 I1% mercaptoethanol, 0-1 M Tris-HCl at pH 7-6 to 0-5 ml of the membrane suspension, and the solution was incubated at 37°C for 30 minutes. Suspensions containing ,ug of the membrane proteins with 2% SDS, 6% sucrose, and Bromophenol blue were applied for electrophoresis. They were introduced by gravity flow through a 20 ul Dummond microcap and discharged gently on to the top of the gel.
Electrophoresis was performed with the current at 8 mA along each tube. The running time was about 90 minutes. The electrophoresis process was carried out in an apparatus that could run six columns simultaneously. The position of the tracking dye was marked in each gel by pricking it with a fine syringe needle dipped with Indian ink. Duplicate gels, unstained, were sliced and applied for radioactivity screening.
Commercially available proteins of known molecular weight were used as markers for molecular weight calibration of the gel. The protein standards used were as follows: bovine serum albumin, human gammaglobulin, ovalbumin, IgG, cytochrome-C, and pepsin.
EXTRACTION OF PROTEIN AND LIPID
Lipids and proteins were extracted from whole blood, plasma, and erythrocyte according to the method described by Ong and Lee."
IDENTIFICATION OF HAEMOGLOBIN ON G-75
Samples of haemolysate were separated by gel filtration chromatography on Sephadex G-75. The basic procedure was similar to that of Takeda et al. 15 After incubation with 10 uCi of 203Pb, the erythrocytes were washed twice with saline buffer and lysed with six volumes of double distilled water. The stroma was removed by centrifugation at 30 000 g, and the supernatant was then converted to cyanhaemoglobin by adding 50 ,umol of sodium cyanide. The lysate was then dialysed against 500 volumes of 0-1 M Tris-HCI buffer, pH 8-1, at 5°C, containing 50 ,umol of CN-, with two changes overnight. The Sephadex column (40 x 18 cm), which had been calibrated with globulin, albumin, and pepsin, was equilibrated with the same buffer overnight. Thirty mg of the lysate were layered on to the column and eluted with 0-1 M Tris-HCl buffer.
The haemoglobin fraction was scanned at 495 or 539 nm or both. Fractions absorbing at 280 nm for protein were also recorded. All fractions were determined for radioactivity. The erythrocyte membranes were prepared as described in the methods section. The membrane (ghosts) pellet was then washed three times to remove the cations loosely associated with the membrane, leaving those 203Pb ions that were firmly bound. The labelled stromal membranes were then dissolved in an excess of SDS, and the polypeptides were denatured and separated in polyacrylamide gel according to the methods of Fairbanks et al.14 Figure 3 shows the densitometric scan of Coomassie-blue stained ghosts polypeptide after electrophoresis in SDS. The (1) The prominent radioactivity peak was ap-9 parently associated with high molecular weight o polypeptide II and its subordinate components.
These polypeptides are known to have a molecular 0-2 weight of about 130 000 to 230 000.
(2) Trace amounts of radioactive lead were recovered in polypeptides III and IV. There was also .0 some in polypeptide V. Figure 4 is the chromatogram of haemolysate separated by G-75 and shows (a) the elution characteristics of the protein band with the calibrated graph suggest a mean molecular weight of 67 000, which is virtually that of haemoglobin polypeptide, and (b) the radioactive peak together with the protein and haemoglobin all appeared on the same fractions (fraction 68 to 73).
ASSOCIATION OF LEAD WITH INTRACELLULAR CONSTITUENT
The radioactive labelled material lost in the chromatography column is only a small amount (8%) in comparison to the binding in the protein fraction; it is reasonable therefore to conclude that haemoglobin is the principal molecule interacting with the 203Pb.
A similar result was obtained with haemolysate, which had been in direct contact with 203Pb in vitro for 60 minutes, suggesting that the organised red cell plays little part in determining binding site and that the initial binding is probably of a chemical or physical type rather than through a complex of biological sequences. -01 
